About Index Trending news
Analyze
Top 50 Pricing
Inspyr

Inspyr

Inspyr

GenSpera, Inc. (OTCQB: $GNSZ) is a development stage oncology company focused on therapeutics that deliver a potent, unique & patented drug directly to tumors.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital (Series Undisclosed)
$2,500,000
Venture capital
$280,000
Employees

Team size

2
Locations
Xconomy

Roundup: J&J and AT&T Grow in Houston, Inspyr and Meshify Move On

Funding Health
Xconomy

Inspyr Leaves San Antonio for California to Be Near Clinical Trials

Health City life
Xconomy

Inspyr Seeks Clinical Partner for Cash After New Name, Exec Hires

Xconomy

Inspyr, Formerly GenSpera, Replaces Co-Founder Dionne With New CEO

Strategy Funding
Xconomy

GenSpera, Pursuing Partners, Tests Toxin-Based Drug in Brain Cancer